Stock Fundamentals

Company Information

Company Name
Immutep Ltd ADR
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US45257L1089
CIK: 0001692528
CUSIP: 74154B302
Currency: USD
Full Time Employees: 0
Phone: 61 2 8315 7003
Fiscal Year End: June
IPO Date: Apr 17, 2012
Description:

Immutep Limited, a biotechnology company, engages in developing novel Lymphocyte Activation Gene-3 related immunotherapies for cancer and autoimmune diseases in Australia. Its lead product candidate is the eftilagimod alfa (efti or IMP321), a soluble LAG-3lg fusion based on LAG-3 immune control mechanism for the treatment of different types of cancers. The company's product pipeline also includes TACTI-004, which is in phase III clinical trial for the treatment of first line non-small cell lung cancer (1L NSCLC); TACTI-003, which is in phase IIb clinical trial to treat first line head and neck squamous cell carcinoma (HNSCC); INSIGHT-005 which is in phase I for metastatic urothelial carcinoma; TACTI-002, which in phase II trial for the treatment NSCLC and HNSCC; AIPAC-003, which is in phase II/III clinical trial to treat metatastic breast cancer; and EFTISARC-NEO, which is in phase II clinical trial for the treatment of soft tissue sarcoma. It also develops INSIGHT-003, which is in phase I trial 1L non squamous NSCL; INSIGHT-005 that is in phase I to treat metastatic urothelial cancer; IMP761, which is in phase I Trial to treat autoimmune disease; IMP731 for oncology and autoimmune diseases; and LAG525. Immutep has collaboration with Merck & Co., Inc., EOC Pharma, Novartis, and Laboratory Corporation of America Holdings. The company was formerly known as Prima BioMed Ltd and changed its name to Immutep Limited in November 2017. The company was incorporated in 1987 and is based in Sydney, Australia.

Address:

Australia Square, Sydney, NSW, Australia, 2000

Directors & Officers

Name Title Year Born
Mr. Marc Voigt CEO, MD, CFO, Chief Business Officer & Executive Director 1973
Ms. Deanne Miller LLB COO, General Counsel & Joint Company Secretary 1977
Dr. Frederic Triebel M.D., Ph.D. Chief Scientific Officer & Executive Director 1955
Mr. Christian Mueller BBA, MSc. Chief Development Officer NA
Dr. Stephan Winckels M.D., Ph.D. Chief Medical Officer NA
Ms. Indira Naidu Joint Company Secretary NA

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 810.93K Mar 31, 2026 0.55% $0.00 -1.53%
UBS Group AG 748.81K Mar 31, 2026 0.51% $0.00 963.38%
Meridian Wealth Management, LLC 449.55K Mar 31, 2026 0.31% $0.01 -1.07%
Two Sigma Investments LLC 124.76K Mar 31, 2026 0.08% $0.00 31.89%
Citadel Advisors Llc 78.17K Mar 31, 2026 0.05% $0.00 0.00%
XTX Topco Ltd 73.84K Mar 31, 2026 0.05% $0.00 0.00%
TWO SIGMA SECURITIES, LLC 53.59K Mar 31, 2026 0.04% $0.00 0.00%
Virtu Financial LLC 41.35K Mar 31, 2026 0.03% $0.00 0.00%
LPL Financial Corp 33.98K Mar 31, 2026 0.02% $0.00 0.00%
Dimensional Fund Advisors, Inc. 30.41K Mar 31, 2026 0.02% $0.00 -8.19%
Quadrature Capital Limited 26.91K Mar 31, 2026 0.02% $0.00 0.00%
Rhumbline Advisers 22.05K Mar 31, 2026 0.02% $0.00 -18.77%
Millennium Management LLC 20.80K Mar 31, 2026 0.01% $0.00 -80.51%
Group One Trading, LP 19.70K Dec 31, 2025 0.01% $0.00 65,556.67%
Geode Capital Management, LLC 18.72K Mar 31, 2026 0.01% $0.00 0.00%
Tower Research Capital LLC 15.80K Mar 31, 2026 0.01% $0.00 0.00%
Morgan Stanley - Brokerage Accounts 11.97K Mar 31, 2026 0.01% $0.00 82.15%
Blair William & Co 11.00K Mar 31, 2026 0.01% $0.00 -40.76%
Commonwealth Equity Services Inc 10.45K Mar 31, 2026 0.01% $0.00 0.00%
Jane Street Group LLC 10.21K Mar 31, 2026 0.01% $0.00 -66.02%

Shares Statistics

Shares Outstanding: 147.37M
Shares Float: 1.28B
% Insiders: 1.20%
% Institutions: 243.10%
Short % Float: 3.59%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 iShares Biotechnology ETF 727.36K 0.49% ▲ 0.64% Apr 30, 2026
2 Fidelity Nasdaq Composite Index 18.72K 0.01% ▲ 0.00% Mar 31, 2026
3 Brighthouse/Dimensional Intl Sm Cm A 8.89K 0.01% ▲ 0.00% Mar 31, 2026
4 DFA International Core Equity Class F 5.41K 0.00% ▲ 0.00% Feb 28, 2026
5 LVIP Dimensional Intl Core Eq Std 4.95K 0.00% ▲ 0.00% Mar 31, 2026
6 DFA Intl Sustainability Core 1 4.30K 0.00% ▲ 0.00% Mar 31, 2026
7 DFA International Core Equity 2 I 3.71K 0.00% ▼ 33.85% Mar 31, 2026

Valuation Metrics

Enterprise Value: $-14.22M
Trailing P/E: 0.00
Forward P/E: 7.13

Financial Highlights

Market Cap: $61.31M
EBITDA: $-82.39M
Book Value: $0.48
Earnings/Share: $-0.38
Profit Margin: 0.00%
Operating Margin: -763.71%
ROA (TTM): -32.10%
ROE (TTM): -61.85%
Revenue (TTM): $7.92M
Revenue/Share (TTM): $0.05
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 91.50%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-06-30 11.69x 0.01x 0.09x N/A -0.02x
2024-06-30 18.25x 0.01x 0.06x -2,879.79x -0.03x
2023-06-30 13.81x 0.01x 0.07x -3,808.07x -0.03x
2022-06-30 14.16x 0.02x 0.08x -367.17x -0.07x
2021-06-30 12.81x 0.04x 0.11x -3,224.10x -0.17x
2020-06-30 9.26x 0.27x 0.29x -1,531.88x -0.78x
2019-06-30 4.44x 0.31x 0.40x N/A -0.46x
2018-06-30 7.43x 0.20x 0.29x N/A -0.64x
2017-06-30 6.05x 0.22x 0.24x N/A -0.69x
2016-06-30 14.72x 0.14x 0.17x -7,497.79x -0.08x
2015-06-30 1.83x 0.06x 0.20x -0.76x -0.11x
2014-06-30 8.91x 0.00x 0.11x N/A 0.00x
2013-06-30 8.93x 0.00x 0.11x N/A 0.00x
2012-06-30 9.20x 0.00x 0.11x N/A 0.00x
2011-06-30 22.49x 0.00x 0.04x -2.21x 0.00x
2010-06-30 7.55x 0.04x 0.12x -4.41x -0.06x
2009-06-30 2.03x 0.13x 0.27x -15.82x -0.09x
2008-06-30 6.29x 0.00x 0.07x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about IMMP.US!